Literature DB >> 18292481

Gabapentin for intractable hiccups in palliative care.

Monica L Tegeler1, Steven J Baumrucker.   

Abstract

Intractable hiccups are not common in the general population or in the palliative care population but can adversely impact quality of life and cause other complications such as weight loss and sleep disturbance. Many treatments have been proposed for intractable hiccups, but there is little consensus regarding treatment in the medical literature. This is partly because hiccups are relatively uncommon and many of the proposed treatments are unproven or have long-term side effects. Pharmacologic treatments rather than home remedies or surgical treatments are more appropriate for the palliative care patient. Gabapentin is a promising medication for the treatment of intractable hiccups for its safety, lack of serious side effects, and rapid onset of action. Further research is indicated to determine whether gabapentin is consistently effective.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18292481     DOI: 10.1177/1049909107305657

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  4 in total

1.  Acupuncture treatment for persistent hiccups in patients with cancer.

Authors:  Adeline X Y Ge; Mary E Ryan; Giuseppe Giaccone; Marybeth S Hughes; Steven Z Pavletic
Journal:  J Altern Complement Med       Date:  2010-07       Impact factor: 2.579

2.  Ultrasound-guided Pulsed Radiofrequency Lesioning of the Phrenic Nerve in a Patient with Intractable Hiccup.

Authors:  Keum Nae Kang; In Kyung Park; Jeong Hun Suh; Jeong Gill Leem; Jin Woo Shin
Journal:  Korean J Pain       Date:  2010-08-26

3.  Hiccup: mystery, nature and treatment.

Authors:  Full-Young Chang; Ching-Liang Lu
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

4.  Gabapentin in the treatment of persistent hiccups in advanced malignancy.

Authors:  Mahesh Menon
Journal:  Indian J Palliat Care       Date:  2012-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.